iifl-logo

Kabra Drugs Ltd EGM

Add as a Preferred Source on Google
28.55
(0.42%)
Jan 8, 2026|02:56:00 PM

Kabra Drugs CORPORATE ACTIONS

08/01/2025calendar-icon
08/01/2026calendar-icon
PurposeAnnouncement DateMeeting Date
EGM28 Nov 202526 Dec 2025
Outcome of Board Meeting held on 28th November 2025, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Notice of Extra Ordinary General Meeting held on 26th December 2025 at Friday. (As Per BSE Announcement Dated on:03.12.2025) Outcome of EGM (As Per BSE Announcement Dated on:26.12.2025) EGM Scrutinizers Report (As per BSE Announcement dated on: 27.12.2025)

Kabra Drugs: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.